Biomed Design, LLC and its affiliate company, Biomedical Design, Inc., have developed patented methods, BDLink™ and BDSter™, both liquid, non-gluteraldehyde tissue preparation processes, used for the treatment of biological tissue prior to surgical implantation.

BDLink™ Cross-linked Tissue

  • Non-toxic
  • Biocompatible
  • Resistant to calcification
  • Soft, pliable and durable tissue
  • Resistant to enzymatic degradation
  • Potential to modulate or customize rate of degradation post-implantation

BDSter™ Sterilized Tissue

  • Compatible with BDLink™ Cross-linked Tissue
  • Sterilant for both organic and inorganic materials
  • Effective sterilant against hard-to-kill bacteria
  • Terminally sterile process

Portfolio of Intellectual Property



All patents include international counterparts.

United States Patent and Trademark Office

Better Than Other Processes

Contact us for a comprehensive technology overview.